{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:52:11Z","timestamp":1787647931554,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T00:00:00Z","timestamp":1396483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s10549-014-2928-4","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T13:50:08Z","timestamp":1396446608000},"page":"233-243","source":"Crossref","is-referenced-by-count":39,"title":["Long-term risk of medical conditions associated with breast cancer treatment"],"prefix":"10.1007","volume":"145","author":[{"given":"Deirdre A.","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora K.","family":"Horick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Domchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail E.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan T.","family":"Lowery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita Y.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia G.","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E.","family":"Plon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrois","family":"Ziogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance A.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol H.","family":"Kasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne M.","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"issue":"4","key":"2928_CR1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3322\/caac.21149","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E (2012) Cancer treatment and survivorship statistics. CA Cancer J Clin 62(4):220\u2013241. doi: 10.3322\/caac.21149","journal-title":"CA Cancer J Clin"},{"key":"2928_CR2","unstructured":"Dictionary of Cancer Terms. http:\/\/www.cancer.gov\/dictionary?cdrid=390292 . Accessed 14 Sept 2013"},{"issue":"11","key":"2928_CR3","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/1055-9965.EPI-09-1245","volume":"19","author":"SA Norman","year":"2010","unstructured":"Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, Miller LT, Fox KR, DeMichele A, Solin LJ (2010) Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev 19(11):2734\u20132746. doi: 10.1158\/1055-9965","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2928_CR4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10549-011-1667-z","volume":"130","author":"RL Ahmed","year":"2011","unstructured":"Ahmed RL, Schmitz KH, Prizment AE, Folsom AR (2011) Risk factors for lymphedema in breast cancer survivors, the Iowa Women\u2019s Health Study. Breast Cancer Res Treat 130(3):981\u2013991. doi: 10.1007\/s10549-011-1667-z","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"2928_CR5","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1200\/JCO.2007.11.6798","volume":"26","author":"PE Goss","year":"2008","unstructured":"Goss PE, Ingle JN, Pater JL, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Cameron DA, Palmer MJ, Tu D (2008) Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5\u00a0years of tamoxifen. J Clin Oncol 26(12):1948\u20131955. doi: 10.1200\/JCO.2007.11.6798","journal-title":"J Clin Oncol"},{"issue":"7","key":"2928_CR6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","volume":"26","author":"R Eastell","year":"2008","unstructured":"Eastell R, Adams JE, Coleman RE, Howell A, Hannon RA, Cuzick J, Mackey JR, Beckmann MW, Clack G (2008) Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol 26(7):1051\u20131057. doi: 10.1200\/JCO.2007.11.0726","journal-title":"J Clin Oncol"},{"issue":"8 Suppl","key":"2928_CR7","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1002\/cncr.27465","volume":"118","author":"KM Winters-Stone","year":"2012","unstructured":"Winters-Stone KM, Schwartz AL, Hayes SC, Fabian CJ, Campbell KL (2012) A prospective model of care for breast cancer rehabilitation: bone health and arthralgia. Cancer 118(8 Suppl):2288\u20132299. doi: 10.1002\/cncr.27465","journal-title":"Cancer"},{"key":"2928_CR8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-10-337","volume":"10","author":"LA Smith","year":"2010","unstructured":"Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, Jones A (2010) Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer 10:337. doi: 10.1186\/1471-2407-10-337","journal-title":"BMC Cancer"},{"issue":"21","key":"2928_CR9","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1200\/JCO.2009.23.6950","volume":"28","author":"SD Russell","year":"2010","unstructured":"Russell SD, Blackwell KL, Lawrence J, Pippen JE Jr, Roe MT, Wood F, Paton V, Holmgren E, Mahaffey KW (2010) Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trials. J Clin Oncol 28(21):3416\u20133421. doi: 10.1200\/JCO.2009.23.6950","journal-title":"J Clin Oncol"},{"issue":"25","key":"2928_CR10","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1200\/JCO.2006.10.4976","volume":"25","author":"MC Pinder","year":"2007","unstructured":"Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH (2007) Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25(25):3808\u20133815. doi: 10.1200\/jco.2006.10.4976","journal-title":"J Clin Oncol"},{"issue":"8","key":"2928_CR11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.2007.11.8877","volume":"26","author":"PA Ganz","year":"2008","unstructured":"Ganz PA, Hussey MA, Moinpour CM, Unger JM, Hutchins LF, Dakhil SR, Giguere JK, Goodwin JW, Martino S, Albain KS (2008) Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897. J Clin Oncol 26(8):1223\u20131230. doi: 10.1200\/JCO.2007.11.8877","journal-title":"J Clin Oncol"},{"issue":"6","key":"2928_CR12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/jnci\/dji067","volume":"97","author":"SH Giordano","year":"2005","unstructured":"Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS (2005) Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97(6):419\u2013424. doi: 10.1093\/jnci\/dji067","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2928_CR13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1470-2045(05)70251-5","volume":"6","author":"SC Darby","year":"2005","unstructured":"Darby SC, McGale P, Taylor CW, Peto R (2005) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6(8):557\u2013565. doi: 10.1016\/S1470-2045(05)70251-5","journal-title":"Lancet Oncol"},{"issue":"15","key":"2928_CR14","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1200\/JCO.2004.03.098","volume":"22","author":"J Bonneterre","year":"2004","unstructured":"Bonneterre J, Roche H, Kerbrat P, Fumoleau P, Goudier MJ, Fargeot P, Montcuquet P, Clavere P, Barats JC, Monnier A, Veyret C, Datchary J, Van Praagh I, Chapelle-Marcillac I (2004) Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100\u00a0mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group. J Clin Oncol 22(15):3070\u20133079. doi: 10.1200\/JCO.2004.03.098-22\/15\/3070","journal-title":"J Clin Oncol"},{"issue":"6","key":"2928_CR15","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9","volume":"92","author":"JA Petrek","year":"2001","unstructured":"Petrek JA, Senie RT, Peters M, Rosen PP (2001) Lymphedema in a cohort of breast carcinoma survivors 20\u00a0years after diagnosis. Cancer 92(6):1368\u20131377. doi: 10.1002\/1097-0142(20010915)92:6<1368:aid-cncr1459>3.0.co;2-9","journal-title":"Cancer"},{"issue":"32","key":"2928_CR16","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ (2008) Prevalence of lymphedema in women with breast cancer 5\u00a0years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26(32):5213\u20135219. doi: 10.1200\/JCO.2008.16.3725","journal-title":"J Clin Oncol"},{"issue":"1","key":"2928_CR17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","volume":"14","author":"TJ Powles","year":"1996","unstructured":"Powles TJ, Hickish T, Kanis JA, Tidy A, Ashley S (1996) Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 14(1):78\u201384","journal-title":"J Clin Oncol"},{"issue":"4","key":"2928_CR18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.2005.02.3515","volume":"24","author":"L Vehmanen","year":"2006","unstructured":"Vehmanen L, Elomaa I, Blomqvist C, Saarto T (2006) Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J Clin Oncol 24(4):675\u2013680. doi: 10.1200\/JCO.2005.02.3515","journal-title":"J Clin Oncol"},{"issue":"9453","key":"2928_CR19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","volume":"365","author":"A Howell","year":"2005","unstructured":"Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5\u00a0years\u2019 adjuvant treatment for breast cancer. Lancet 365(9453):60\u201362. doi: 10.1016\/S0140-6736(04)17666-6","journal-title":"Lancet"},{"issue":"2","key":"2928_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1470-2045(07)70003-7","volume":"8","author":"RE Coleman","year":"2007","unstructured":"Coleman RE, Banks LM, Girgis SI, Kilburn LS, Vrdoljak E, Fox J, Cawthorn SJ, Patel A, Snowdon CF, Hall E, Bliss JM, Coombes RC (2007) Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study. Lancet Oncol 8(2):119\u2013127. doi: 10.1016\/S1470-2045(07)70003-7","journal-title":"Lancet Oncol"},{"issue":"34","key":"2928_CR21","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1200\/JCO.2005.02.5841","volume":"23","author":"JJ Doyle","year":"2005","unstructured":"Doyle JJ, Neugut AI, Jacobson JS, Grann VR, Hershman DL (2005) Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol 23(34):8597\u20138605. doi: 10.1200\/JCO.2005.02.5841","journal-title":"J Clin Oncol"},{"issue":"3","key":"2928_CR22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000078165","volume":"6","author":"H Anton-Culver","year":"2003","unstructured":"Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, Rimer B, Schildkraut J, Strong L, Weber B, Winn D, Hiatt R, Nayfield S (2003) The Cancer Genetics Network: recruitment results and pilot studies. Commun Genet 6(3):171\u2013177","journal-title":"Commun Genet"},{"key":"2928_CR23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2288-11-72","volume":"11","author":"V Gupta","year":"2011","unstructured":"Gupta V, Gu K, Chen Z, Lu W, Shu XO, Zheng Y (2011) Concordance of self-reported and medical chart information on cancer diagnosis and treatment. BMC Med Res Methodol 11:72. doi: 10.1186\/1471-2288-11-72","journal-title":"BMC Med Res Methodol"},{"issue":"21","key":"2928_CR24","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1200\/JCO.2005.03.002","volume":"23","author":"KA Phillips","year":"2005","unstructured":"Phillips KA, Milne RL, Buys S, Friedlander ML, Ward JH, McCredie MR, Giles GG, Hopper JL (2005) Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. J Clin Oncol 23(21):4679\u20134686. doi: 10.1200\/JCO.2005.03.002","journal-title":"J Clin Oncol"},{"issue":"10","key":"2928_CR25","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jclinepi.2004.04.005","volume":"57","author":"Y Okura","year":"2004","unstructured":"Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ (2004) Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57(10):1096\u20131103. doi: 10.1016\/j.jclinepi.2004.04.005","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2928_CR26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/oxfordjournals.aje.a114319","volume":"123","author":"GA Colditz","year":"1986","unstructured":"Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123(5):894\u2013900","journal-title":"Am J Epidemiol"},{"issue":"3","key":"2928_CR27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2008.17.9291","volume":"27","author":"SA Norman","year":"2009","unstructured":"Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, Miller LT, DeMichele A, Solin LJ (2009) Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 27(3):390\u2013397. doi: 10.1200\/jco.2008.17.9291","journal-title":"J Clin Oncol"},{"issue":"17","key":"2928_CR28","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/jnci\/djs317","volume":"104","author":"EJ Bowles","year":"2012","unstructured":"Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, McCarty C, Magid DJ, Wagner EH (2012) Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst 104(17):1293\u20131305. doi: 10.1093\/jnci\/djs317","journal-title":"J Natl Cancer Inst"},{"issue":"25","key":"2928_CR29","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1200\/JCO.2005.05.1037","volume":"24","author":"EE Harris","year":"2006","unstructured":"Harris EE, Correa C, Hwang WT, Liao J, Litt HI, Ferrari VA, Solin LJ (2006) Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 24(25):4100\u20134106. doi: 10.1200\/JCO.2005.05.1037","journal-title":"J Clin Oncol"},{"issue":"4","key":"2928_CR30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jacc.2010.08.638","volume":"57","author":"K Bouillon","year":"2011","unstructured":"Bouillon K, Haddy N, Delaloge S, Garbay JR, Garsi JP, Brindel P, Mousannif A, Le MG, Labbe M, Arriagada R, Jougla E, Chavaudra J, Diallo I, Rubino C, de Vathaire F (2011) Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol 57(4):445\u2013452. doi: 10.1016\/j.jacc.2010.08.638","journal-title":"J Am Coll Cardiol"},{"key":"2928_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2407-7-9","volume":"7","author":"R Roychoudhuri","year":"2007","unstructured":"Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Moller H (2007) Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer 7:9. doi: 10.1186\/1471-2407-7-9","journal-title":"BMC Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2928-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-2928-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2928-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T01:01:37Z","timestamp":1565312497000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-2928-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["2928"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-2928-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,3]]}}}